The weekly litigation news digest is live. Subscribe now

IP Verse

Heterodimers Of Glutamic Acid

Patent No. EP3699162 (titled "Heterodimers Of Glutamic Acid") was filed by Molecular Insight Pharmaceuticals on Nov 7, 2007. The application was issued on Jun 29, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TELIX INNOVATIONSJan 10, 2023DE CLERCQ & PARTNERS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3699162

MOLECULAR INSIGHT PHARMACEUTICALS
Application Number
EP19214298A
Filing Date
Nov 7, 2007
Status
Granted And Under Opposition
May 27, 2022
Publication Date
Jun 29, 2022
External Links
Slate, Register, Google Patents